Immune evasion driven by lipid metabolic reprogramming in endocrine-resistant HR+ breast cancer: antigen presentation defects and T-cell dysfunction

Lutian Gong, Yujing Zhao, Minglu Che, Xiangyang Zhang, Dongni Zhang, Wenping Lu · 2026

Read Immune evasion driven by lipid metabolic reprogramming in endocrine-resistant HR+ breast cancer: antigen presentation defects and T-cell dysfunction by Lutian Gong, Yujing Zhao, Minglu Che, Xiangyang Zhang, Dongni Zhang, Wenping Lu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13582620.txt.

Description

Gong and co-authors review how fat metabolism helps hormone-sensitive breast cancers resist hormone therapy and hide from the immune system. These cancers often stop answering endocrine treatment, and they also respond poorly to immunotherapy. The review argues the two problems are linked through lipids. Inside tumor cells, faster fat burning, more fat building, and shifted cholesterol handling can dull the machinery that displays tumor markers to immune cells.

In the tissue around the tumor, extra lipid can cripple the sentinel cells that present those markers and push other immune cells toward suppressive roles. T cells then get weak, constant stimulation and slide into exhaustion. The authors tie these threads into one axis running from lipid change to failed presentation to T-cell failure. They offer the map as a basis for pairing metabolic drugs with immune therapy in resistant disease.

Catalog record

CREATORLutian Gong, Yujing Zhao, Minglu Che, Xiangyang Zhang, Dongni Zhang, Wenping Lu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13582620

Browse the full library · About the Tower of Babel